Zobrazeno 1 - 10
of 189
pro vyhledávání: '"José Luis, Ferreiro"'
Autor:
Kristian Rivera, Diego Fernández-Rodrígue, Marcos García-Guimarães, Juan Casanova-Sandoval, Patricia Irigaray, Marta Zielonka, Tania Ramírez Martínez, David Arroyo-Calpe, Joan Costa-Mateu, María Tornel-Cerezo, Anna Baiget-Pons, Oriol Roig-Boira, Eduard Perelló-Cortí, Xenia Castillo-Peña, Raquel Royo-Beltrán, Fernando Worner, José Luis Ferreiro
Publikováno v:
REC: Interventional Cardiology, Vol 6, Iss 4, Pp 287-295 (2024)
RESUMEN Introducción y objetivos: Actualmente, el acceso radial distal (ARD) para procedimientos coronarios es una alternativa al acceso radial convencional, con algunas ventajas descritas principalmente en términos de complicaciones relacionadas c
Externí odkaz:
https://doaj.org/article/e3fa305cbe6e4a00a1e9b27de20760f8
Autor:
Kristian Rivera, Diego Fernández-Rodríguez, Marcos García-Guimarães, Juan Casanova-Sandoval, Patricia Irigaray, Marta Zielonka, Tania Ramírez Martínez, David Arroyo-Calpe, Joan Costa-Mateu, María Tornel-Cerezo, Anna Baiget-Pons, Oriol Roig-Boira, Eduard Perelló-Cortí, Xenia Castillo-Peña, Raquel Royo-Beltrán, Fernando Worner, José Luis Ferreiro
Publikováno v:
REC: Interventional Cardiology (English Ed.), Vol 6, Iss 4, Pp 287-295 (2024)
ABSTRACT Introduction and objectives: Distal radial access (DRA) for coronary procedures is currently recognized as an alternative to conventional transradial access, with documented advantages primarily related to access-related complications. Howev
Externí odkaz:
https://doaj.org/article/0f0b15575d3d475f970fba0252070447
Autor:
Mar Rocamora-Horrach, Óscar M. Peiró, Alfredo Bardají, Javier Flores-Benítez, Miguel Ivorra-Cámara, Anna Carrasquer, José Luis Ferreiro
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundCardiovascular disease has traditionally been studied predominantly in men, but understanding its manifestations in women is crucial for effective management. This study aims to evaluate the long-term prognosis of female patients with acute
Externí odkaz:
https://doaj.org/article/d7e0da1c332b43d891c272913b1f94bc
Autor:
Josep Gomez‐Lara, Montserrat Gracida, Fernando Rivero, Alejandro Gutiérrez‐Barrios, Guillem Muntané‐Carol, Rafael Romaguera, Lara Fuentes, Ana Marcano, Gerard Roura, José Luis Ferreiro, Luis Teruel, Salvatore Brugaletta, Fernando Alfonso, Josep Comín‐Colet, Joan‐Antoni Gomez‐Hospital
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 13 (2023)
Background ST‐segment–elevation myocardial infarction complicated with no reflow after primary percutaneous coronary intervention is associated with adverse outcomes. Although several hyperemic drugs have been shown to improve the Thrombolysis in
Externí odkaz:
https://doaj.org/article/6ca76e19ec0a4af5b896db23d1e35fa4
Autor:
Ana Lucrecia Marcano, Montserrat Gracida, Gerard Roura, Josep Gomez-Lara, Rafael Romaguera, Luis Teruel, Lara Fuentes, Guillem Muntané-Carol, Oona Meroño, Silvia Gabriela Sosa, Joan Antoni Gómez-Hospital, Josep Comin-Colet, José Luis Ferreiro
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
IntroductionPatients with diabetes mellitus (DM) have augmented platelet reactivity and diminished responsiveness to clopidogrel. Ticagrelor, a more potent P2Y12 inhibitor, is clinically superior to clopidogrel in acute coronary syndromes, although i
Externí odkaz:
https://doaj.org/article/1e83d0d921b24d6ba7e7792f64a0da71
Autor:
Pablo Díez-Villanueva, César Jiménez-Méndez, José Luis Ferreiro, Pedro Cepas-Guillén, Clara Bonanad, Sergio García-Blas, Albert Ariza-Solé, Juan Sanchís, Manuel Martínez-Sellés
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 24, Iss 7, p 201 (2023)
Non-ST segment elevation myocardial infarction (NSTEMI) is the most frequent type of acute coronary syndrome in the elderly. Antithrombotic therapy is the cornerstone of pharmacological therapy in the setting of an acute ischemic event, a clinical sc
Externí odkaz:
https://doaj.org/article/07ff64b1648b42218c52fd925b8918d4
Publikováno v:
REC: Interventional Cardiology (English Ed.), Vol 2, Iss 4, Pp 244-246 (2020)
During the second half of 2019, cangrelor started selling in our country, a “new” antiplatelet drug with especial pharmacological properties that make it especially appealing for the management of certain clinical situations in the percutaneous c
Externí odkaz:
https://doaj.org/article/d7ccf5a106f9420e9a3a1e828323f95c
Publikováno v:
REC: Interventional Cardiology, Vol 2, Iss 4, Pp 244-246 (2020)
Durante la segunda mitad de 2019 se inició en nuestro país la comercialización del cangrelor, un «nuevo» antiagregante plaquetario con características farmacológicas singulares que lo hacen atractivo para determinadas situaciones clínicas en
Externí odkaz:
https://doaj.org/article/2bf4243a8b854f889ccc4ef2456d155c
Autor:
Juan M. Ruiz-Nodar, José Luis Ferreiro
Publikováno v:
REC: Interventional Cardiology (English Ed.), Vol 1, Iss 1, Pp 41-50 (2019)
Abstract The antithrombotic treatment after percutaneous revascularization in patients with chronic indication for oral anticoagulation has always been a matter of great interest and complexity, basically because of the high ischemic and thromboembol
Externí odkaz:
https://doaj.org/article/d57efec9926042abaa779e9bcc9726f9
Autor:
Juan M. Ruiz-Nodar, José Luis Ferreiro
Publikováno v:
REC: Interventional Cardiology, Vol 1, Iss 1, Pp 41-50 (2019)
Resumen El tratamiento antitrombótico tras una revascularización percutánea en los pacientes con indicación de anticoagulación oral crónica ha sido siempre un tema de máximo interés y de gran complejidad, debido sobre todo al alto riesgo isqu
Externí odkaz:
https://doaj.org/article/ec1edd30edc64a15963fcc389c344b06